Form 4: TransMedics Group CFO Awarded Stock Options and Restricted Stock Units

TransMedics Group's Chief Financial Officer, Gerardo Hernandez, received stock options and restricted stock units as part of his compensation package.

Summary

• TransMedics Group, Inc. has filed a Form 4 disclosing that Chief Financial Officer Gerardo Hernandez was granted stock options and restricted stock units.
• The stock options allow Mr. Hernandez to purchase 18,922 shares of common stock at a price of $69.84 per share.
• Additionally, Mr. Hernandez received 12,463 restricted stock units (RSUs), each representing a contingent right to receive one share of the company's common stock.
• The stock options vest 25% on December 2, 2025, and the remaining shares vest in equal monthly installments over three years, contingent on continued service.
• The RSUs also vest over time, subject to continued service.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally positive for aligning management and shareholder interests. There are no indications of negative issues.

Positives

• The grant of stock options and RSUs aligns the CFO's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CFO.

Risks

• The value of the stock options and RSUs is dependent on the future performance of the company's stock price.
• If Mr. Hernandez leaves the company before the vesting period is complete, he may forfeit some or all of the unvested options and RSUs.

Future Outlook

The vesting of the stock options and RSUs is contingent on the CFO's continued service, suggesting a focus on long-term performance and retention.

Industry Context

Stock option and RSU grants are a common form of executive compensation in the technology and healthcare industries, aligning management's interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a standard practice for executive compensation across many industries, particularly in growth-oriented companies like TransMedics.
• The vesting schedule of 25% after one year and the remainder over three years is a typical vesting structure for stock options and RSUs.
• Companies like Intuitive Surgical (ISRG) and Edwards Lifesciences (EW) also use stock-based compensation to incentivize their executives.

Stakeholder Impact

• Shareholders may view the stock option and RSU grants as a positive sign of management's commitment to the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, restricted stock units, RSUs, compensation, executive compensation, vesting, TransMedics Group, TMDX, CFO, Gerardo Hernandez